(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FARBRIDGE PHARMA CONSULTING

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

FARBRIDGE PHARMA CONSULTING

ST13

US500000099258951

Class

42

Filing

99258951

Registration

8134452

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

02/11/2026

Trademark type

Combined

Nice classes

42

Filing date

06/30/2025

Registration date

02/10/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/10/2026

Last transaction

02/11/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

07/17/2023

First use in commerce

07/17/2023

Drawing code

3

Owner type

16

Owner location

San Diego, CA

Examiner

ALLEN, BIANCA LEIGH

Law office

N50

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of a stylized whirlpool symbol that transitions from light blue to dark blue in a clockwise direction. To the right of the design is the stylized gray wording "FARBRIDGE", below which is the stylized gray wording "PHARMA CONSULTING". The white in the drawing represents background and is not a feature of the mark.

Holders and representatives

Holders

Farbridge Pharma Consulting, LLC

Representatives

Edward N. Benito Benito Law Firm PC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Consulting services in the field of biotechnology; Consulting services in the field of genetic science; Consulting services in the field of pharmaceutical research and development; Pharmaceutical drug development services

Publications

History of USPTO decisions and trademark events.

15 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/10/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/10/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/23/2025

PUBO

PUBLISHED FOR OPPOSITION

12/23/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/17/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/24/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

11/24/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/24/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

11/24/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/24/2025

DOCK

ASSIGNED TO EXAMINER

11/18/2025

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/07/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/07/2025

MAFR

APPLICATION FILING RECEIPT MAILED

06/30/2025

NWAP

NEW APPLICATION ENTERED

06/30/2025

Continuous trademark protection

Get notified about every new filing that threatens FARBRIDGE PHARMA CONSULTING or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.